Intracellular Th
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $175,159 | $161,388 | $144,866 | $131,506 |
Gross Profit | 159,855 | 150,034 | 134,966 | 120,804 |
EBITDA | -38,711 | -27,594 | -20,820 | -33,961 |
EBIT | -38,849 | -27,723 | -20,952 | -34,097 |
Net Income | -26,324 | -16,219 | -15,247 | -28,579 |
Net Change In Cash | 175,159 | 161,388 | 144,866 | 131,506 |
Free Cash Flow | -27,221 | 489 | -34,116 | -2,062 |
Cash | 464,312 | 695,056 | 141,569 | 147,767 |
Basic Shares | 105,768 | 103,723 | 96,875 | 96,285 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $462,175 | $249,132 | $81,707 | $22,530 |
Gross Profit | 428,430 | 228,689 | 73,673 | 20,635 |
EBITDA | -158,853 | -262,970 | -285,154 | -230,699 |
EBIT | -159,381 | -263,626 | -285,688 | -231,227 |
Net Income | -139,674 | -256,256 | -284,125 | -227,005 |
Net Change In Cash | 462,175 | 249,132 | 81,707 | 22,530 |
Cost of Revenue | 56,600 | 32,319 | -46,190 | |
Free Cash Flow | -124,468 | -270,964 | -259,869 | -230,339 |
Cash | 147,767 | 148,615 | 92,364 | 60,045 |
Basic Shares | 95,881 | 94,046 | 81,253 | 70,364 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.25 |
2024-06-30 | -$0.16 |
2024-03-31 | -$0.16 |
2023-12-31 | -$0.30 |
